RNAC
Cartesian Therapeutics Inc.
$5.97
-$0.21(-3.48%)
37
Overall
40
Value
30
Tech
42
Quality
Market Cap
$166.48M
Volume
149.82K
52W Range
$5.60 - $15.57
Target Price
$35.57
Key Metrics Overview
| Market Cap | $166.48M | P/E Ratio | N/A |
| 52W High | $15.57 | 52W Low | $5.60 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 12.1% | 52W Position | 3.7% |
| Overall Score | 37 | Value Score | 40 |
| Quality Score | 42 | Technical Score | 30 |
Growth Analysis
| EPS Current Est | $-3.26 | EPS Next Est | $-3.73 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $5.97 | -3.5% | 149.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW